Science director: Kris Gevaert

At CMB, the focus lies on the development of new and innovative molecular tools and technologies to address human health problems. An emerging and fascinating research theme is the development and production of new biopharmaceuticals and vaccines. CMB researchers are working on new applications in tuberculosis research, cancer treatment and antiviral immunity, among others. Research at CMB pushes the boundaries of biomolecular/bioinformatics research and engineering. We also translate our new technologies and insights into widely applicable research tools, vaccines, diagnostics and pharmaceuticals.